COMMUNIQUÉS West-GlobeNewswire

How assessURhealth™ worked to #EndTheStigma in 2017
01/01/2018
Tampa, Jan. 01, 2018 (GLOBE NEWSWIRE) -- assessURhealth, LLC , a leading provider of mental and behavioral health screening software, took their mission to new heights in 2017. Expanding their integration capabilities [...]
Veloxis Announces the Total Number of Shares and Voting Rights in the Company as of 31 December 2017
31/12/2017
Company Release no. 27/2017 To: NASDAQ Copenhagen A/S Copenhagen, Denmark, 31 December 2017 Veloxis Announces the Total Number of Shares and Voting Rights in the Company as of 31 December 2017 Veloxis Pharmaceuticals A/ [...]
Helius Medical Technologies Announces Closing of Final Tranche of Private Placement
30/12/2017
NEWTOWN, Pa., Dec. 29, 2017 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (TSX: HSM ) (TSX:HSM.WT) (OTCQB:HSDT) (“Helius” or the “Company”), a medical technology company focused on neurological wellness, is [...]
Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
30/12/2017
CAMBRIDGE, Mass., Dec. 29, 2017 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ: SRPT ), a commercial-stage biopharmaceutical company focused on the discovery and development of precision genetic medicines to [...]
SELLAS Life Sciences Group Successfully Completes Business Combination with Galena Biopharma
29/12/2017
HAMILTON, Bermuda and NEW YORK, Dec. 29, 2017 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (Nasdaq: SLS ) (SELLAS Inc.) today announced that the proposed merger of the businesses of SELLAS Life Sciences Group [...]
Edge's EG-1962 Phase 3 NEWTON 2 Study Continues as Planned Following Completion of Futility Analysis
29/12/2017
BERKELEY HEIGHTS, N.J., Dec. 29, 2017 (GLOBE NEWSWIRE) -- Edge Therapeutics, Inc. (Nasdaq: EDGE ), a clinical-stage biotechnology company developing novel hospital-based therapies for the management of acute, life- [...]
Bio-Path Holdings Provides Clinical Update and 2018 Business Outlook
29/12/2017
HOUSTON, Dec. 29, 2017 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc., (NASDAQ: BPTH ), a biotechnology company leveraging its proprietary DNAbilize ® antisense RNAi nanoparticle technology to develop a portfolio of [...]
Medovex Corporation Converts IDE Submission to a Pre-Submission with Food and Drug Administration for its DenerveX System
29/12/2017
ATLANTA, Dec. 29, 2017 (GLOBE NEWSWIRE) -- Medovex Corp. (OTCQB:MDVX) ("Medovex" or the "Company"), the developer of the DenerveX® System, a new and novel device designed for enduring relief of Facet Joint Syndrome [...]
ContraVir Pharmaceuticals Announces John Sullivan-Bolyai, M.D., MPH Steps Down as Chief Medical Officer
29/12/2017
EDISON, N.J., Dec. 29, 2017 (GLOBE NEWSWIRE) -- ContraVir Pharmaceuticals, Inc. (NASDAQ: CTRV ), announced today that John Sullivan-Bolyai will step down as Chief Medical Officer and take on a new role in the company, [...]
United American Healthcare Corporation’s Subsidiaries show strong Third Quarter Fiscal Year 2017 Results
29/12/2017
CHICAGO, Dec. 29, 2017 (GLOBE NEWSWIRE) -- United American Healthcare Corporation (the “Company”), today announced that it plans to release its consolidated financial operational results for the three and nine months [...]
Repligen To Present at 36th Annual J.P. Morgan Healthcare Conference
29/12/2017
WALTHAM, Mass., Dec. 29, 2017 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ: RGEN ), a leading bioprocessing-focused company delivering technology innovation to improve biologic drug manufacturing flexibility and [...]
Veloxis Pharmaceuticals Announces Financial Calendar for 2018
29/12/2017
Company Release no. 26/2017 To: NASDAQ Copenhagen A/S Copenhagen, Denmark, 29 December 2017 Veloxis Pharmaceuticals Announces Financial Calendar for 2018 Veloxis Pharmaceuticals A/S today announced its financial [...]
Medtronic Chairman and CEO Omar Ishrak to Speak at J.P. Morgan Healthcare Conference
29/12/2017
DUBLIN - December 29, 2017 - Medtronic plc (NYSE: MDT ), the global leader in medical technology, today announced it will participate in the 36th Annual J.P. Morgan Healthcare Conference on Monday, January 8, 2018, in [...]
Saniona AB: Saniona Establish Equity Financing of up to SEK 144 million
29/12/2017
PRESS RELEASE December 29, 2017 Saniona AB, a leading biotech company in the field of ion channels, announced today that it has entered into a convertible notes funding agreement with Nice & Green S.A. Under the [...]
Canada House Wellness Group Announces The Retirement of Interim CEO Gerry Goldberg
29/12/2017
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES TORONTO, Dec. 29, 2017 (GLOBE NEWSWIRE) -- Canada House Wellness Group Inc. (CSE:CHV) (“ Canada House ” or the “ Company ”) announces [...]
Galena Biopharma, Inc. Stockholders Approve Business Combination with SELLAS Life Sciences Group, Ltd; Board Sets Reverse Stock Split Ratio
29/12/2017
SAN RAMON, Calif., Dec. 29, 2017 (GLOBE NEWSWIRE) -- Galena Biopharma, Inc. (NASDAQ: GALE ) (“Galena”) announced today that its stockholders approved nine proposals at the reconvened Special Meeting of Stockholders held [...]
Alpha Pro Tech, Ltd. Names Lloyd Hoffman as President; Appoints Donna Millar to Board of Directors
29/12/2017
NOGALES, Ariz., Dec. 29, 2017 (GLOBE NEWSWIRE) -- Alpha Pro Tech, Ltd. (NYSE American: APT), a leading manufacturer of products designed to protect people, products and environments, including disposable protective [...]
Delcath Announces Exit from Convertible Note
29/12/2017
NEW YORK, Dec. 29, 2017 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (OTCQB:DCTH), an interventional oncology company focused on the treatment of primary and metastatic liver cancers, announces on December 28, 2017, it [...]
Progenics Pharmaceuticals Announces FDA Acceptance of New Drug Application for AZEDRA® (iobenguane I 131) in Pheochromocytoma and Paraganglioma
29/12/2017
NEW YORK, Dec. 29, 2017 (GLOBE NEWSWIRE) -- Progenics Pharmaceuticals, Inc. (NASDAQ: PGNX ), an oncology company developing innovative medicines and imaging analytical tools for targeting and treating cancer, announced [...]

Pages